PLN-101325

N/A

Report date: 2022/07/06 14:08:55

Base Information

Drug NamePLN-101325
Drug Alias NamePLN-101325
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIntegrin alpha7/beta1 agonists
TargetsIntegrin alpha7/beta1
Therapy Area/IndicationsMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A